Ignite Creation Date:
2024-05-05 @ 11:53 PM
Last Modification Date:
2024-10-26 @ 10:41 AM
Study NCT ID:
NCT01440595
Status:
TERMINATED
Last Update Posted:
2024-05-22
First Post:
2011-09-22
Brief Title:
Grazoprevir MK-5172 With Peg-Interferon and Ribavirin in Participants With Chronic Genotype 2 or 3 Hepatitis C MK-5172-012
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-11-28
Start Date Type:
ACTUAL
Primary Completion Date:
2012-05-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-05-01
Completion Date Type:
ACTUAL
First Submit Date:
2011-09-22
First Submit QC Date:
September 22 2011
Study First Post Date:
2011-09-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2016-03-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-20
Last Update Post Date:
2024-05-22
Last Update Post Date Type:
ACTUAL